chr19-7895700-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025061.6(LRRC8E):c.97G>A(p.Val33Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000936 in 1,614,090 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_025061.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC8E | NM_025061.6 | c.97G>A | p.Val33Met | missense_variant | 2/3 | ENST00000306708.11 | NP_079337.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC8E | ENST00000306708.11 | c.97G>A | p.Val33Met | missense_variant | 2/3 | 1 | NM_025061.6 | ENSP00000306524.5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251368Hom.: 1 AF XY: 0.000155 AC XY: 21AN XY: 135872
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461816Hom.: 2 Cov.: 31 AF XY: 0.0000990 AC XY: 72AN XY: 727216
GnomAD4 genome AF: 0.000164 AC: 25AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2024 | The c.97G>A (p.V33M) alteration is located in exon 2 (coding exon 1) of the LRRC8E gene. This alteration results from a G to A substitution at nucleotide position 97, causing the valine (V) at amino acid position 33 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at